High Court's Stanford Ruling Puts Special Demands on Life Sciences, Attorneys Say

June 17, 2011

Attorneys and life sciences companies expressed concern that, as a result of the Supreme Court's June 6 ruling that the Bayh-Dole Act does not bar inventors from assigning their individual rights in patents resulting from federally funded research, a research organization's efforts to properly secure rights to that invention will become more complicated and more demands will be placed on life sciences research than on other areas.

Reproduced with permission from Life Sciences Law & Industry Report, 5 LSLR 597 (June 17, 2011). Copyright 2011 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Related Publications

November 19, 2022
How to Use the USPTO Patent Public Search Tool
Miles Finn, Rajin Olson, Kelson Bain, and Ian LaForge - IPWatchdog
October 2022
In No Uncertain Terms
Bryan Mechell - The Robins Kaplan Quarterly
September 13, 2022
Patent Value: Scoring Patents Using Characteristics Of Patents In Litigation
Christopher K. Larus, Miles A. Finn, Congnan Zhan, Joseph (Yu) Chen, and Shelley Gilliss - les Nouvelles
September 2, 2022
Trade Dress Through a Trial Lens: Six Strategy Tips For Litigants
Christopher Larus, William Manske - Managing IP
August 25, 2022
Back to Top